Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValereum Plc Regulatory News (VLRM.PL)

Share Price Information for Valereum Plc (VLRM.PL)

Share Price is delayed by 15 minutes
Get Live Data
2.60    0.10 (4.00%)
Bid:
2.50
Ask:
2.70
Spread: 0.20 (8.00%)
Market Cap: £14.10m
VLRM.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Valereum Plc Share Chart

New Board Appointment

30 Nov 2023 10:00

RNS Number : 1384V
Valereum PLC
30 November 2023

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR")

30/11/2023

Valereum Plc

("Valereum" or the "Company")

New Board Appointment

Valereum Plc (AQUIS: VLRM), the Gibraltar technology group, is today announcing the following new board appointment:

Karl Moss will be joining the Company as Chief Financial Officer (CFO). Karl brings 30 years' experience across financial planning, compliance and corporate finance, including 20 years' Board experience as CFO, delivering sector leading growth leading to significant realisations in shareholder value in the SAL Group and the i2 Group.

The following information is provided for the purpose of Rule 4.9 of the AQSE Growth Market Access Rulebook for Karl Moss.

Current directorships and/or partnerships:?

Former directorships and/or partnerships (within the last five years):?

I2 Analytical Limited

Scientific Analysis Instruments Limited

Gatenet Technology Limited

Mycotoxin Laboratory UK Ltd

I2 Fast Limited

Hallco (479) Limited

None

Karl was Financial Director of REC CHSS Training Limited and its dormant parent holding company Corporate Health & Safety Services Limited. Karl resigned from the company on 19th July 2013. The parent company went into administration on 11th March 2014 following a failed MBO by the management team in preparation for a divestment of the wider group company.

There is no further information to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Access Rulebook.£

The Directors of the Company accept responsibility for the contents of this announcement.

For more information, please visit the Company's website at Valereum.gi

Enquiries:

Valereum Plc

James Formolli, Chairman

Tel: +971 4584 6284

AQSE Corporate Adviser

First Sentinel Corporate Finance

Brian Stockbridge

Tel: +44 20 3855 5551

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXFEMEFUEDSELF
Date   Source Headline
31st May 20243:02 pmRNSAgreed Subscription to Raise £2 million
31st May 202410:10 amRNSPartnership with Securities & Trading Technology
31st May 202410:10 amRNSRemuneration Update - Warrant and Option Issue
12th Apr 20247:00 amRNSAppointment of Corporate Broker
11th Apr 20249:37 amRNSResult of Annual General Meeting - April 2024
28th Mar 20242:00 pmRNSAppointment of PR Agency and Interim Funding
20th Mar 202411:05 amRNSNotice of Annual General Meeting
20th Feb 20247:00 amRNSStrategy Update and the Launch of “The Bridge”
31st Jan 20247:00 amRNSCompletion of the Acquisition of GSX Group
15th Jan 20247:00 amRNSMarket Update on Mattereum
10th Jan 20247:00 amRNSBoard Appointments, Update on EGM and AGM
22nd Dec 202312:09 pmRNSAcquisition of Valereum Collections and AGM Update
18th Dec 20237:00 amRNSAcquisition of the GSX Group
30th Nov 202310:00 amRNSNew Board Appointment
28th Nov 202310:00 amRNSRemoval of CLN’s Update
27th Nov 20237:00 amRNSRestoration to Trading & Update on Acquisition
17th Nov 20237:00 amRNSValereum PLC update on the acquisition of the GSX
27th Oct 20239:05 amRNSAppointment of New Directors
26th Oct 20238:13 amRNSChange of Directors
24th Oct 20232:21 pmRNSGSX Acquisition Update and Director Resignation
3rd Oct 20237:00 amRNSInterim Results for the six months to 30 June 2023
31st Aug 20232:22 pmRNSReverse Takeover & Suspension of Trading
31st Aug 202311:22 amRNSUpdate on the acquisition of the GSX
23rd Aug 20231:36 pmRNSAppointment of Jack Sun as Finance Director
21st Jul 202310:56 amRNSUpdate on GSX Acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.